Iressa Shows Promise For Treatment Of Metastatic Breast Cancer W...

Courtesy ScienceDaily  Mon, 05/19/2008 - 14:00

Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers.


 

More related items

First Step Towards Switching Off Breast Cancer And Leukaemia
Scientists have identified a way to "switch off" a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of...

Breast Cancer Detection: A Simpler Alternative To Mammograms?
Whether a painless, portable device that uses electrical current rather than X-ray to look for breast cancer could be an alternative to traditional...

Gene Panel Predicts Lung Cancer Survival, Study Finds
Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer...

Single-nucleotide Polymorphisms Do Not Substantially Improve...
Recently identified genetic markers, called single nucleotide polymorphisms, that are associated with a small but statistically significant increase...

Marijuana Horticulture: The Indoor/Outdoor Medical Grower's...
With 512 full color pages and 1120 full color photographs and illustrations, Marijuana Horticulture: The Indoor/Outdoor Medical Grower's Bible is the...

Setting-Up a Small Observatory: From Concept to Construction...
This is the book to tell the intermediate-level amateur astronomer what he needs to know about observatories. It draws on the author’s practical...

Complete Bladesmith: Forging Your Way To Perfection
Looking for instructions in bladesmithing that'll put you on the cutting edge of the custom blade market? Then this definitive guide to forging...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com